Brief by Shorts91 Newsdesk / 07:55pm on 27 Jan 2025,Monday Health & Wellness
Scientists at the University of Oxford and GSK are developing a vaccine to stop cancer up to 20 years before it develops. The vaccine targets pre-cancerous cells, using advancements in detecting early cancer signs. GSK will invest £50 million in the research, which aims to identify and attack cancer-prone cells. Professor Sarah Blagden said cancers take years to form, and this vaccine could "detect the undetectable." Over 385,000 people in the UK are diagnosed with cancer annually, with 167,000 deaths. This breakthrough could change the future of cancer prevention and save countless lives.
